Accelerated Resolution Therapy for Early Maladaptive Grief
Mayo Clinic · with National Institute on Aging (NIA) · NCT05624879
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 55+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 440
- US sites recruiting
- 4
- Study start
- November 17, 2023
- Record last updated
- October 19, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose study is to test the effects of accelerated resolution therapy (ART) on pre-loss grief and prolonged grief disorder among older adult family caregivers (FCGs). Additionally, to better understand predictors of response to ART, and cognitive processes that occur among grieving individuals following ART.
Being studied: Accelerated Resolution Therapy; Information and Support
Conditions: Grief
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Primary caregiver of immediate family member who has a life expectancy of less than 12 months
- Score of 30 or higher on the PG-12-R, indicating clinically significant pre-loss grief
- Denial of suicidal ideation or intent, with no evidence of psychotic behavior.
Exclusion Criteria
- Since becoming a family caregiver (FCG), they have engaged in another trauma based psychotherapeutic regimen (EMDR, prolonged exposure therapy, trauma focused cognitive behavioral therapy) that could influence response to accelerated resolution therapy (ART).
- Self-reported or clinically assessed major psychiatric disorder (e.g., bipolar disorder, schizophrenia).
- Score of > 2 on the adapted CAGE questionnaire indicating alcohol /drug dependence.
- Cognitive impairment (SPMSQ > 4 errors).
Recruiting US locations
Mayo Clinic Arizona
Phoenix, AZ 85054
Suncoast Hospice
Clearwater, FL 33760
Site contact: Ronald Featherstone, LCSW
Mayo Clinic Florida
Jacksonville, FL 32224
Mayo Clinic
Rochester, MN 55905
Study contacts (from the official record)
- Katharine E Sheffield, MA, CCRP · 904-953-3972 · Sheffield.Katharine@mayo.edu
Similar studies in Arizona
All healthy volunteers studies in Arizona →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
AstraZeneca
- Location
- Chandler, AZ + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation
Vertex Pharmaceuticals Incorporated
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingHealthy volunteersPhase 1
A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants
Epygenix
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55